• Genetics of osteoporosis and osteogenesis imperfecta

  • New understandings for the genetic basis of Type 2 diabetes and obesity, and the development of new therapeutic and prevention strategies

  • Characterization of growth factors for pancreatic beta cells and their potential clinical use for treatment of Type 1 diabetes

  • Investigation of the long-term effects of blood glucose control on prevention and delay of diabetic complications

  • Optimization of preoperative and postoperative care for patients undergoing pancreas transplantation

  • Optimization of diagnosis and treatment of cardiovascular disease in patients with diabetes

  • Preclinical gene therapy approaches for diabetes

  • Studies to determine why some people respond to certain diabetes drugs while others do not (pharmacogenomics)

  • Clinical trials of new therapeutic agents for the treatment of diabetes and obesity

  • Genetics of hypertension

  • Diagnosis and treatment of osteoporosis associated with kidney failure and transplantation

  • Studies of growth hormone replacement in adults

  • Genetics of longevity

  • Molecular studies of fat cells and how insulin works

For more information, call the University Physicians Consultation and Referral Service at 1-800-492-5538 (patients) or 1-800-373-4111 (physicians). For diabetes referrals please call the University of Maryland Center for Diabetes and Endocrinology at 1-888-567-5468.